Skip to main content
GutCited

Cerebral magnetic resonance imaging in quiescent Crohn's disease patients with fatigue.

Sanne van Erp, Ece Ercan, Perla Breedveld, Lianne Brakenhoff, Eidrees Ghariq et al.
Other World journal of gastroenterology 2017 21 trích dẫn
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D28246475'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Loại nghiên cứu
Observational Study
Cỡ mẫu
37
Đối tượng nghiên cứu
Quiescent Crohn's disease patients with fatigue
Can thiệp
Cerebral magnetic resonance imaging in quiescent Crohn's disease patients with fatigue. None
Đối chứng
healthy controls (n=17)
Kết quả chính
cerebral Glx concentration and CBF
Xu hướng hiệu quả
Negative
Nguy cơ sai lệch
Moderate

Abstract

AIM: To evaluate brain involvement in quiescent Crohn's disease (CD) patients with fatigue using quantitative magnetic resonance imaging (MRI). METHODS: Multiple MRI techniques were used to assess cerebral changes in 20 quiescent CD patients with fatigue (defined with at least 6 points out of an 11-point numeric rating scale compared with 17 healthy age and gender matched controls without fatigue. Furthermore, mental status was assessed by cognitive functioning, based on the neuropsychological inventory including the different domains global cognitive functioning, memory and executive functioning and in addition mood and quality of life scores. Cognitive functioning and mood status were correlated with MRI findings in the both study groups. RESULTS: Reduced glutamate + glutamine (Glx = Glu + Gln) concentrations (P = 0.02) and ratios to total creatine (P = 0.02) were found in CD patients compared with controls. Significant increased Cerebral Blood Flow (P = 0.05) was found in CD patients (53.08 ± 6.14 mL/100 g/min) compared with controls (47.60 ± 8.62 mL/100 g/min). CD patients encountered significantly more depressive symptoms (P < 0.001). Cognitive functioning scores related to memory (P = 0.007) and executive functioning (P = 0.02) were lower in CD patients and both scores showed correlation with depression and anxiety. No correlation was found subcortical volumes between CD patients and controls in the T1-weighted analysis. In addition, no correlation was found between mental status and MRI findings. CONCLUSION: This work shows evidence for perfusion, neurochemical and mental differences in the brain of CD patients with fatigue compared with healthy controls.

Tóm lược

Evidence is shown for perfusion, neurochemical and mental differences in the brain of CD patients with fatigue compared with healthy controls and between mental status and MRI findings.

Used In Evidence Reviews

Similar Papers